risedronic acid has been researched along with Hypertension in 2 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
Excerpt | Relevance | Reference |
---|---|---|
" Adverse event incidence was marginally higher in DL compared with non-DL (Relative risk 1." | 2.82 | Efficacy and Safety of Risedronate in Osteoporosis Subjects with Comorbid Diabetes, Hypertension, and/or Dyslipidemia: A Post Hoc Analysis of Phase III Trials Conducted in Japan. ( Inoue, D; Muraoka, R; Nishizawa, Y; Okazaki, R; Sugimoto, T, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
López-Cedrún, JL | 1 |
Sanromán, JF | 1 |
García, A | 1 |
Peñarrocha, M | 1 |
Feijoo, JF | 1 |
Limeres, J | 1 |
Diz, P | 1 |
Inoue, D | 1 |
Muraoka, R | 1 |
Okazaki, R | 1 |
Nishizawa, Y | 1 |
Sugimoto, T | 1 |
1 trial available for risedronic acid and Hypertension
Article | Year |
---|---|
Efficacy and Safety of Risedronate in Osteoporosis Subjects with Comorbid Diabetes, Hypertension, and/or Dyslipidemia: A Post Hoc Analysis of Phase III Trials Conducted in Japan.
Topics: Adult; Aged; Bone Density; Bone Density Conservation Agents; Comorbidity; Diabetes Mellitus; Double- | 2016 |
1 other study available for risedronic acid and Hypertension
Article | Year |
---|---|
Oral bisphosphonate-related osteonecrosis of the jaws in dental implant patients: a case series.
Topics: Administration, Oral; Adrenal Cortex Hormones; Aged; Alendronate; Bisphosphonate-Associated Osteonec | 2013 |